IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)
Authors:
Open Access
- 23 October 2018
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 29 (suppl_8) , viii743-viii744